Occurrence, characterization and management of fruit rot of immature cucumber fruits under arid greenhouse conditions

A study was undertaken to characterize and manage pathogens associated with fruit rot of immature cucumber fruits in greenhouses in Oman. A survey over 5 growing seasons from 2008 to 2010 in 99 different greenhouses in Oman showed that the disease is prevalent in 91 (92%) greenhouses and results in losses of 10 to 60% (avg. 33%) of immature fruits per plant. Incidence of the disease was not found to be affected by growing seasons, which could be attributed to the limited fluctuations in ambient temperatures in greenhouses. Isolations from diseased cucumber fruits yielded Alternaria alternata (isolation frequency = 52%), Fusarium equiseti (40%), Cladosporium tenuissium (27%), Botrytis cinerea (6%), Fusarium solani (6%), Corynespora cassiicola (3%), Aspergillus spp. (2%), Curvularia sp. (1%) and Bipolaris sp. (1%). With the exception of Curvularia and Bipolaris species, all other fungi were pathogenic on cucumber fruits, with Fusarium equiseti being the most aggressive, followed by Corynespora cassiicola, Botrytis cinerea and Alternaria alternata. Cladosporium and Aspergillus spp. were found to be weakly pathogenic. Comparing the efficacy of foliar and soil applications of carbendazim fungicide on fruit rot of cucumber showed that foliar applications significantly reduced fruit rot and increased cucumber yield when compared to soil application or to control (P < 0.01). This appears to be the first report of the association of Corynespora cassiicola and Fusarium equiseti with fruit rot of immature greenhouse cucumbers. This is also the first report in Oman for the association of Cladosporium tenuissimum with fruit rot of immature cucumbers. Findings are discussed in terms of factors affecting disease control in greenhouses using carbendazim

Extracorporeal liver support in patients with liver failure: a systematic review and meta-analysis of randomized trials

PURPOSE: Acute liver failure (ALF) and acute on chronic liver failure (ACLF) are associated with significant mortality and morbidity. Extracorporeal liver support (ECLS) devices have been used as a bridge to liver transplant; however, the efficacy and safety of ECLS are unclear. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to examine the efficacy and safety of ECLS in liver failure. METHODS: We searched MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials from inception through March 13, 2019. RCTs comparing ECLS to usual care in ALF or ACLF were included. We used the Grading of Recommendations Assessment, Development and Evaluation approach to assess the certainty of the evidence. RESULTS: We identified 25 RCTs (1796 patients). ECLS use was associated with reduction in mortality (RR 0.84; 95% CI 0.74, 0.96, moderate certainty) and improvement in hepatic encephalopathy (HE) (RR 0.71; 95% CI 0.60, 0.84, low certainty) in patients with ALF or ACLF. The effect of ECLS on hypotension (RR 1.46; 95% CI 0.98, 2.2, low certainty), bleeding (RR 1.21; 95% CI 0.88, 1.66, moderate certainty), thrombocytopenia (RR 1.62; 95% CI 1.0, 2.64, very low certainty) and line infection (RR 1.92; 95% CI 0.11, 33.44, low certainty) was uncertain. CONCLUSIONS: ECLS may reduce mortality and improve HE in patients with ALF and ACLF. The effect on other outcomes is uncertain. However, the evidence is limited by risk of bias and imprecision, and larger trials are needed to better determine the effect of ECLS on patient-important outcomes

EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/141073/1/joa3247.pd